ParaMedir’s mission is to improve diagnostic and analytical performance in healthcare and biotech. We strongly believe in the synergy between (bio)sensoring and microfluidic technologies. The new devices will be able to monitor multiple (bio)chemical markers, simultaneously.

ParaMedir aims to bridge the gap between cutting-edge research and clinical care. We are committed to bringing new (bio)monitoring solutions to the bedside and allow doctors and patients to benefit from (bio)sensoring and microfluidic technology.

In early 2024, a consortium led by ParaMedir was recently awarded €1.8 million in European funding from the Just Transition Fund (JTF). Read more about this exciting news in our press release (PDF)!

Privacy policy